Skip to content
HowShorted

Zentalis Pharmaceuticals, Inc. short interest in 2020

In 2020, Zentalis Pharmaceuticals, Inc.'s disclosed short interest ran from 6.38% of shares outstanding on 15 Jul 2020 to 7.40% on 31 Dec 2020, a change of +1.02 percentage points. The year's high was 7.40% on 31 Dec 2020 and its low 4.61% on 15 Sep 2020, averaging 5.69% across 12 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.82 days on 14 Aug 2020. Full history: Zentalis Pharmaceuticals, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Zentalis Pharmaceuticals, Inc. in 2020

2020 in figures

Start of year
6.38% (15 Jul 2020)
End of year
7.40% (31 Dec 2020)
Change
+1.02 pp
High
7.40% (31 Dec 2020)
Low
4.61% (15 Sep 2020)
Average
5.69%
Highest days to cover
24.82 (14 Aug 2020)
SEC filings marked
7

Every report in 2020

Zentalis Pharmaceuticals, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jul 20206.38%19.5510-Q filed, results (8-K)
31 Jul 20206.71%13.69results (8-K)
14 Aug 20206.11%24.8210-Q filed, results (8-K)
31 Aug 20205.92%24.62
15 Sep 20204.61%18.86
30 Sep 20205.26%14.61
15 Oct 20205.29%17.42
30 Oct 20205.78%14.10
13 Nov 20205.28%8.5110-Q filed, results (8-K)
30 Nov 20204.91%8.29
15 Dec 20204.67%5.15
31 Dec 20207.40%4.23

See also: Zentalis Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.